津上机床中国(01651)发布公告，本集团预期取得截至2025年9月30日止6个月的本公司拥有人应占溢利 约人民币5.02亿元，较截至2024年9月30日止6个月的本公司拥有人应占溢利约人民币3.40亿元(未经审 核)增加约48%。 董事会认为，本集团业绩增长受益于国内经济的持续恢复。中国制造业的转型升级，特别是新能源汽 车、人工智能等用户领域的快速发展，给机床行业带来了新的需求，以及公司近年对制造业各细分行业 的持续开拓和渗透，这样也导致对本集团生产的数控高精密机床需求量增加。同时本集团在降本增效改 善及优化经营方面的持续不断的努力显著提升了产品竞争力，同时公司的盈利能力也得以大幅提升。 ...

经济观察网 据大皖新闻消息，10月17日上午，不少用户反映，知乎APP和网页端出现异常。有网民发 布的信息显示，知乎手机APP有页面显示"加载失败"。知乎客服工作人员回应称，"今天上午系统目前 突发异常，工程师团队目前已经在加急的排查中非常抱歉，辛苦耐心等待一下。" ...

Core Viewpoint - GCL-Poly Energy Holdings Limited (协鑫科技) has achieved a turnaround in its photovoltaic materials business, reporting a profit of approximately 960 million yuan in Q3 2025, compared to a loss of 1.81 billion yuan in the same period last year [1][2] Financial Performance - The profit includes a post-tax gain of about 640 million yuan from the sale of an associate company. Excluding this non-recurring income, the photovoltaic materials business still demonstrated robust operational profit [1] - The EBITDA for this business segment reached approximately 1.41 billion yuan, a significant improvement from an adjusted LBITDA of about 571 million yuan in the previous year [1] Pricing and Cost Efficiency - The average external selling price of granular silicon was 42.12 yuan/kg in Q3 2025, a notable increase from 32.93 yuan/kg in Q2 2025, indicating a recovery in market demand for high-quality granular silicon [1] - The average production cash cost of granular silicon (including R&D costs) decreased to 24.16 yuan/kg, down from 27.07 yuan/kg in Q1 2025, showcasing the company's continuous breakthroughs in energy consumption control, process improvement, and economies of scale [2] Strategic Adjustments - In response to intense competition in the photovoltaic industry, the company has adjusted its operational strategy to focus on production based on sales and maintaining low inventory levels, while enhancing collaboration with upstream and downstream partners [2] - The company aims to promote the quality release of granular silicon capacity and optimize its carbon footprint, contributing to a rational return of prices across the entire industry chain and sustainable development [2] Industry Context - Analysts note that the competitive pressure in the industry is driving technological advancements and encouraging companies to build intellectual property defenses, which supports and promotes the country's new quality productivity [2] - The company's ability to achieve profitability in Q3 2025 is attributed to its comprehensive breakthroughs in technology, cost management, talent acquisition, low-carbon initiatives, and market strategies [2]

Core Points - The Henan Financial Regulatory Bureau approved the appointment of Wang Yuansheng as the Vice President of the Zhengzhou Branch of Zhongyuan Bank [1] - The approval requires the appointee to comply with relevant regulatory provisions and to report their onboarding status within three months [1] - Zhongyuan Bank is responsible for ensuring that the appointee continues to learn and understand economic and financial laws and regulations, and to maintain a strong risk compliance awareness [1]

Core Viewpoint - Sunshine Oil Sands (02012) has announced that it received a petition from a registered creditor in Hong Kong, which has been fully settled except for legal fees [1] Group 1: Company Financial Obligations - The company has fully repaid the amounts owed to the petitioner, who is a bondholder, as of the announcement date, excluding legal fees [1] - Lin Zhi Cheng, a third-party individual investor in the company's bonds, has also filed a petition regarding a financial liability of HKD 1.223 million, which has been fully settled by the company as of the announcement date, excluding legal fees [1] Group 2: Impact on Financial Performance - The board believes that since the financial information related to the bonds held by the creditors has been recorded in the company's financial statements, the settled obligations will not have a significant adverse impact on the company's financial performance and condition [1]

Core Points - Geely Automobile announced the issuance of 30,500 ordinary shares on October 17, 2025, due to employees exercising stock options under a plan adopted on April 28, 2023 [1] - An additional 10,000 ordinary shares will be issued on the same date due to related entity participants exercising stock options under the same plan [1]

Core Viewpoint - 基石药业's drug, Sugli monoclonal antibody, received a positive opinion from the European Medicines Agency (EMA) for the treatment of adult patients with unresectable stage III non-small cell lung cancer (NSCLC) who have PD-L1 expression ≥1% and have not progressed after platinum-based chemoradiotherapy [1] Group 1: Company Developments - The CEO of 基石药业, Dr. Yang Jianxin, expressed satisfaction with the rapid and positive progress of the EMA review for Sugli monoclonal antibody, marking the second positive recommendation from CHMP within a year [1] - If approved, Sugli monoclonal antibody will solidify its position as a core immunotherapy for lung cancer, significantly enhancing its market position and commercial potential [1] - The company aims to collaborate with partners to accelerate the comprehensive launch of Sugli monoclonal antibody in the European market, providing high-quality and affordable treatment options for more patients [1] Group 2: Clinical Research Insights - The positive opinion for the new indication of Sugli monoclonal antibody is based on the GEMSTONE-301 study, a multicenter, randomized, double-blind phase III clinical trial demonstrating dual benefits in progression-free survival and overall survival for stage III NSCLC patients [1] - If the new indication is approved, Sugli monoclonal antibody will become the second PD-(L)1 antibody approved for stage III NSCLC in Europe, addressing a critical need in this disease area and offering new hope for patients [1] - The efficient positive opinion from CHMP is seen as recognition of the clinical development and registration team's efforts at 基石药业, reinforcing the commitment to meet the urgent medical needs of patients in China and globally [1]

Core Viewpoint - Geely Automobile announced the issuance of 30,500 ordinary shares on October 17, 2025, due to employees exercising stock options under a plan adopted on April 28, 2023 [1] - An additional 10,000 ordinary shares will be issued on the same date due to related entity participants exercising stock options under the same plan [1] Summary by Category - **Share Issuance** - 30,500 ordinary shares will be issued on October 17, 2025, as a result of employees exercising stock options [1] - 10,000 ordinary shares will be issued on the same date due to related entity participants exercising stock options [1] - **Stock Option Plan** - The stock option plan was adopted on April 28, 2023, and is the basis for the share issuance [1]

Core Viewpoint - The company has settled all financial obligations to the bondholders and does not expect any significant adverse impact on its financial performance or condition from the recent legal proceedings [1] Group 1: Legal Proceedings - The company received a petition from a registered bondholder in Hong Kong on August 20, 2025, and has published an announcement on the same day [1] - The bondholder had previously invested in the company's issued bonds and has been fully paid, excluding legal fees [1] - A third-party individual investor, Lin Zhi Cheng, has also filed a notice to appear in the hearing regarding a financial obligation of HKD 1.223 million, which the company has also fully settled, excluding legal fees [1] Group 2: Financial Impact - The board of directors believes that since the financial information related to the bonds has been recorded in the company's financial statements, the settled obligations will not have a significant adverse effect on the company's financial performance and condition [1]

Core Viewpoint - ZTO Express (02057) announced a share repurchase plan, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Group 1: Share Repurchase Details - The company plans to repurchase 265,600 shares at a total cost of $5.033 million [1] - The repurchase price is set between $18.87 and $18.99 per share [1]